Cyclo Therapeutics Stock Market Value
| CYTH Stock | USD 0.68 0.05 6.85% |
| Symbol | Cyclo |
Cyclo Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclo Therapeutics. If investors know Cyclo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share 0.046 | Quarterly Revenue Growth 0.051 | Return On Assets (2.82) | Return On Equity (226.64) |
The market value of Cyclo Therapeutics is measured differently than its book value, which is the value of Cyclo that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cyclo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclo Therapeutics' market value can be influenced by many factors that don't directly affect Cyclo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cyclo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cyclo Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cyclo Therapeutics.
| 12/08/2022 |
| 11/27/2024 |
If you would invest 0.00 in Cyclo Therapeutics on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding Cyclo Therapeutics or generate 0.0% return on investment in Cyclo Therapeutics over 720 days. Cyclo Therapeutics is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment... More
Cyclo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cyclo Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cyclo Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 25.0 | |||
| Value At Risk | (5.19) | |||
| Potential Upside | 5.33 |
Cyclo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyclo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cyclo Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cyclo Therapeutics historical prices to predict the future Cyclo Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | (0.60) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclo Therapeutics Backtested Returns
Cyclo Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0238, which signifies that the company had a -0.0238% return per unit of standard deviation over the last 3 months. Cyclo Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cyclo Therapeutics' mean deviation of 3.39, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cyclo Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cyclo Therapeutics is expected to be smaller as well. At this point, Cyclo Therapeutics has a negative expected return of -0.1%. Please make sure to confirm Cyclo Therapeutics' jensen alpha, as well as the relationship between the skewness and day median price , to decide if Cyclo Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.06 |
Virtually no predictability
Cyclo Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Cyclo Therapeutics time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cyclo Therapeutics price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Cyclo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Cyclo Therapeutics lagged returns against current returns
Autocorrelation, which is Cyclo Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cyclo Therapeutics' stock expected returns. We can calculate the autocorrelation of Cyclo Therapeutics returns to help us make a trade decision. For example, suppose you find that Cyclo Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cyclo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cyclo Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cyclo Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cyclo Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Cyclo Therapeutics Lagged Returns
When evaluating Cyclo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cyclo Therapeutics stock have on its future price. Cyclo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cyclo Therapeutics autocorrelation shows the relationship between Cyclo Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Cyclo Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Cyclo Therapeutics is a strong investment it is important to analyze Cyclo Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cyclo Therapeutics' future performance. For an informed investment choice regarding Cyclo Stock, refer to the following important reports:Check out Cyclo Therapeutics Correlation, Cyclo Therapeutics Volatility and Cyclo Therapeutics Alpha and Beta module to complement your research on Cyclo Therapeutics. For more detail on how to invest in Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Cyclo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.